[978] Assessment of TMPRSS2:ERG (T:E) Gene Fusion in Prostatic Adenocarcinomas with Mixed Acinar (PCA-A) and Ductal (PCA-D) Components: Comparison of ERG Break-Apart and T:E Fusion Probes
C Sherer, K Cieply, A Liang, A Perepletchikov, A Parwani, R Dhir, T McHale, J Salvatore, L Niemeier, S Bastacky. University of Pittsburgh, Pittsburgh, PA
Background: T:E fusion is present in many PCAs. Most studies have used an ERG break-apart probe to assess ERG disruption as a surrogate marker of T:E fusion. A T:E fusion probe assay is now available to directly assesses T:E fusion. The aim of this study was to compare both methods in pts with PCA (A+D).
Design: Formalin-fixed, paraffin-embedded sections from 19 PCA pts and 9 organ donor prostates (ODP) were obtained from the tissue bank of the University of Pittsburgh. Dxs were confirmed prior to ERG and T:E FISH. All pts had PCA (A+ D) on initial bxs (n=5) or resections (n=14), and some had benign prostate tissue (BPT). PCA-A, PCA-D, and BPT were targeted. Dual-color FISH using either a break-apart probe for ERG disruption or separate probes assessing T:E fusion were compared. Cases were positive if > 20% of cells had ERG disruption or T:E fusion, with thresholds based on ODPs.
Results:
| PCA (A or D) | PCA-A | PCA-D | PCA (A+D) | BPT | |
| ERG (+/total cases (%)) | 14/19 (74%) | 9/16 (56%) | 14/19 (74%) | 9/16 (56%) | 3/10 (30%)* |
| TE (+/total cases (%)) | 15/19 (79%) | 11/17 (65%) | 9/15 (60%) | 7/11 (64%) | 0/18 (0%) |
| p-value | > 0.05 | > 0.05 | > 0.05 | > 0.05 | > 0.05 |
| Gleason score | ERG+ | T:E+ | p-value |
| 3+4=7 | 4/6 (67%) | 4/6 (65%) | p>0.05 |
| 4+3=7 | 6/8 (75%) | 8/8 (100%)* | p>0.05 |
| 4+4=8 | 3/4 (75%) | 3/4 (75%) | p>0.05 |
| 4+5=9 | 1/1 (100%) | 1/1 (100%) | p>0.05 |